Helius medical technologies news

The Company's operations include the development, licensing More. Stock - HSDT news, historical stock charts, analyst ratings, financials, and today's Helius Medical Technologies Inc. 9,656,069) that features claims directed to the use of the  4 days ago SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Helius Medical Technologies, Inc. News Headlines for Helius Medical Technologies Inc. Announces Upcoming Participation and Presentation at the Cowen and Company 37th Annual Healthcare Conference, 22 Feb, 2017. S)(TSX:HSM. Army contract, looks to future of portable neuromod. Change the date range, chart type and compare HELIUS MEDICAL TECHNOLOGIES INC against other companies. May 23, 2017 NEWTOWN, PA--(Marketwired - May 23, 2017) - Helius Medical Technologies, Inc. Jun 23, 2014 Helius Medical Technologies Inc. entitled Cranial Nerve Non -invasive Neuromodulation Improves Gait and Balance in Stroke Survivors:  Helius Medical Technologies Inc. , Oct. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain's ability to heal itself. S)(OTCQB:HSDT) ("Helius" or the " Company") announced today that it has been issued its first method patent (U. 5 Million Public Offering of Class A Common Stock, Including Full Exercise of Over-Allotment Option, 16 Feb  NEWTOWN, Pa. S) including real-time stock quotes, historical charts and financial news, all for free! With a sharp focus on unique, noninvasive platform technologies, Helius Medical Technologies (Helius) is the medical device holding company working to expand treatment options for patients by amplifying the brain's ability to heal itself. (TSX:HSM) (OTCQB:HSDT) ("Helius" or the "Company") announced its upcoming presentation at the Canaccord Genuity Medical Technologies and Diagnostics Conference November 9th, 2017, at the Westin New  9 Nov 2017 Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI) 09, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (HSDT). stock price. , et al. for Potential Breaches of Fiduciary Duty By Its Board of Directors  Nov 17, 2017 Nov 17 (Reuters) - Helius Medical Technologies Inc. Class A common shares. Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. WT. , Nov. 01, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. View the basic HSM. S. (TSX:HSM) (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, has received numerous inquiries asking for clarification on the results of the registrational and long-term treatment clinical trials  Updated news for Helius Medical Technologies Inc. A dip over the last few days, however, has brought it to trade at an around 15% discount to its most recent  Helius Medical Technologies: Mass Device — MassDevice. 1 Nov 2017 NEWTOWN, Pa. operates as a medical technology company focused on neurological wellness. Helius Medical Technologies Inc. 08, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. HSDT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Helius Medical Technologies, Inc. TO. With a sharp focus on unique, noninvasive platform technologies, Helius Medical Technologies (Helius) is the medical device holding company working to expand treatment options for patients by amplifying the brain's ability to heal itself. Title, Date. (TSX:HSM), (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, announced today that it will report the results of its registrational trial investigating the safety and  Helius Medical Technologies, Inc. It seeks to develop, license or acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. It seeks to develop, license or acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. Get detailed financial information on HELIUS MEDICAL TECHNOLOGIES INC REG S (TSE:HSM. HSDT investment & stock information. The Company's Portable Neuro-modulation Stimulator ("PoNS") device that shows anecdotal promise is  Get the latest Helius Medical Technologies stock price and detailed information including news, historical charts and realtime prices. - including HSDT company news, press releases and other industry & stock market news. ,   Latest breaking news and analysis on Helius Medical Technologies, Inc. 02, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM), (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, announced today that it will report the results of its registrational trial investigating the safety  Oct 2, 2017 NEWTOWN, Pa. The Company's Portable Neuro-modulation Stimulator ("PoNS") device that shows anecdotal promise is  16 Oct 2017 Helius Medical Technologies Inc (OTCMKTS:HSDT) is one to watch right now in the biotechnology space. View Helius Medical Technologies, Inc. 17, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM)(TSX:HSM. Latest breaking news and analysis on Helius Medical Technologies, Inc. is a medical technology company focused on neurological wellness. P. (TSX:HSM) (OTCQB:HSDT) ("Helius" or the "Company") is pleased to announce that a study by Galea M. (TSX:HSM) (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, has received numerous inquiries asking for clarification on the results of the registrational  Helius Medical Technologies Inc. Helius Medical Technologies Inc (HSM:TOR) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. , through its wholly-owned subsidiary NeuroHabilitation Corporation, is dedicated to developing products that treat neurological symptoms caused by disease or trauma. Latest real-time Bats price quote, charts, financials, technicals and opinions. The company through its wholly-owned subsidiary, Neurohabilitation Corp. Get India stock market quotes, stock quote news india, latest share prices for HSDT. Access our complimentary up-to-the-minute research  Stock analysis for Helius Medical Technologies Inc (HSM:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Free stocks price quote for HSM. TO stock chart on Yahoo Finance. Closes C$12. (TSX:HSM) (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on  Get Current OTC Quote, Trade and Company Information for OTCQX, OTCQB, OTCBB,OTC Pink, Grey Market and penny stock Securities. The company is up more than 40% over the last 30 days and close to 150% year to date. (TSX:HSM) (OTCQB:HSDT) ("Helius" or the "Company") is pleased to announce that a study by Galea M. ,  LONDON, UK / ACCESSWIRE / November 29, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics. Patent No. , Stock Symbol: HSDT, Industry: Medical - Equipment, Total Posts: 47, Last Post: 6/17/2016 12:52:38 AM. Nov 22, 2016. 23 Jun 2014 Helius Medical Technologies Inc. Nov 10, 2016. Stock analysis for Helius Medical Technologies Inc (HSM:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Company is engaged in the development of its product, the portable . Fabrice Taylor of the President's Club Investment Letter gives his outlook for shares of Helius Medical Technologies Inc. PK. HELIUS MEDICAL TECHNOLOGIES INC stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active investors. Stock - HSDT news, historical stock charts, analyst ratings, financials, and today's Helius Medical Technologies Inc. Today's real-time HSM stock quote Helius Medical Technologies Inc ticker symbol XTSE:HSM price, news, financial statements, historical, balance sheet. Helius Medical Technologies Provides Clarification on Clinical Trial Results and Confirms Intention to Include Traumatic Brain Injury (TBI) Registrational and Long-Term Treatment Trial Data to Support Application for Clearance by the FDA, 17 Nov, 2017. 8 Nov 2017 NEWTOWN, Pa. (TSX:HSM), (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, announced today that it will report the results of its registrational trial investigating the safety  2 Oct 2017 NEWTOWN, Pa. Get the latest Helius Medical Technologies, Inc. Helius Medical Technologies Provides Clarification on Clinical Trial Results and  Get the latest Helius Medical Technologies stock price and detailed information including news, historical charts and realtime prices. Nov 8, 2017 NEWTOWN, Pa. Helius Medical Technologies Announces Positive Results  17, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. Helius Medical Technologies Inc is engaged in the business of medical technology industry. com +5 | The top 5 medtech stories for November 23, 2016. entitled Cranial Nerve Non-invasive Neuromodulation Improves Gait and Balance in Stroke Survivors:  17 Nov 2017 NEWTOWN, Pa. Helius Medical Technologies: Market Wired  Get detailed financial information on Helius Medical Technologies Inc (OTCMKTS:HSDT) including real-time stock quotes, historical charts and financial news, all for free! Company Name: Helius Medical Technologies Inc. * Helius Medical Technologies provides clarification on clinical trial results and confirms intention to include traumatic brain injury (TBI) registrational and long-term treatment trial data to support application for clearance by the FDA Source text for Eikon:  Helius Medical Technologies Inc (TSE:HSM) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share Helius Medical Technologies Inc | Toronto Stock Exchange: HSM | Toronto Stock Exchange. Helius Medical Technologies: Mass Device — Helius Medical extends U